Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James A Levi

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Toxicology in Vitro : an International Journal Published in Association with BIBRA|March 14, 2025
High-throughput assay for predicting diarrhea risk using a 2D human intestinal stem cell-derived modelColleen M Pike, James A Levi, Lauren A Boone, et al.
Biorxiv : the Preprint Server for Biology|September 11, 2024
High-Throughput Assay for Predicting Diarrhea Risk Using a 2D Human Intestinal Stem Cell-Derived ModelColleen M Pike, James A Levi, Lauren A Boone, et al.
Biorxiv : the Preprint Server for Biology|October 4, 2023
Characterization and optimization of variability in a human colonic epithelium culture modelColleen M Pike, Bailey Zwarycz, Bryan E McQueen, et al.
ALTEX|April 20, 2024
Characterization and optimization of variability in a human colonic epithelium culture modelColleen M Pike, Bailey Zwarycz, Bryan E McQueen, et al.
ACS Omega|September 13, 2022
Vandetanib Blocks the Cytokine Storm in SARS-CoV-2-Infected MiceAna C Puhl, Giovanni F Gomes, Samara Damasceno, et al.
Biorxiv : the Preprint Server for Biology|January 4, 2022
Vandetanib Reduces Inflammatory Cytokines and Ameliorates COVID-19 in Infected MiceAna C Puhl, Giovanni F Gomes, Samara Damasceno, et al.
Biorxiv : the Preprint Server for Biology|December 10, 2020
Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine and Pyronaridine: In vitro Activity Against SARS-CoV-2 and Potential MechanismsAna C Puhl, Ethan James Fritch, Thomas R Lane, et al.
ACS Omega|March 29, 2021
Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine, and Pyronaridine: <i>In Vitro</i> Activity against SARS-CoV-2 and Potential MechanismsAna C Puhl, Ethan J Fritch, Thomas R Lane, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Toxicology in Vitro : an International Journal Published in Association with BIBRA|March 14, 2025
High-throughput assay for predicting diarrhea risk using a 2D human intestinal stem cell-derived modelColleen M Pike, James A Levi, Lauren A Boone, et al.
Biorxiv : the Preprint Server for Biology|September 11, 2024
High-Throughput Assay for Predicting Diarrhea Risk Using a 2D Human Intestinal Stem Cell-Derived ModelColleen M Pike, James A Levi, Lauren A Boone, et al.
Biorxiv : the Preprint Server for Biology|October 4, 2023
Characterization and optimization of variability in a human colonic epithelium culture modelColleen M Pike, Bailey Zwarycz, Bryan E McQueen, et al.
ALTEX|April 20, 2024
Characterization and optimization of variability in a human colonic epithelium culture modelColleen M Pike, Bailey Zwarycz, Bryan E McQueen, et al.
ACS Omega|September 13, 2022
Vandetanib Blocks the Cytokine Storm in SARS-CoV-2-Infected MiceAna C Puhl, Giovanni F Gomes, Samara Damasceno, et al.
Biorxiv : the Preprint Server for Biology|January 4, 2022
Vandetanib Reduces Inflammatory Cytokines and Ameliorates COVID-19 in Infected MiceAna C Puhl, Giovanni F Gomes, Samara Damasceno, et al.
Biorxiv : the Preprint Server for Biology|December 10, 2020
Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine and Pyronaridine: In vitro Activity Against SARS-CoV-2 and Potential MechanismsAna C Puhl, Ethan James Fritch, Thomas R Lane, et al.
ACS Omega|March 29, 2021
Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine, and Pyronaridine: <i>In Vitro</i> Activity against SARS-CoV-2 and Potential MechanismsAna C Puhl, Ethan J Fritch, Thomas R Lane, et al.
Pageof 1